Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on Apr 11, 2023 11:17am
557 Views
Post# 35388484

Traferox Technologies Inc...another part of the ecosystem

Traferox Technologies Inc...another part of the ecosystem

Over the last couple decades Shaf has acted on his vision and created an ecosystem that SQI has become an important part of.  While this remains a relatively unknown fact, it is very much the case.
  
In order to perform personalized medicine, it is necessary to have top notch multiplex diagnostics, and especially when they can be performed at point of need in only minutes.  

Prof. Keshavjee is a founder, shareholder, and Chief Medical Officer of Traferox Technologies Inc. and a consultant for Lung Bioengineering.

Prof. Cypel is a founder and shareholder of Traferox Technologies and a consultant for Lung Bioengineering.

Don't underestimate the importance SQI plays in providing the personalized component.  Better evaluation equates to higher quality and more frequent transplants.  

<< Previous
Bullboard Posts
Next >>